Research

An Unexpected Threat to HPV

A nutritional supplement derived from mushrooms shows promise in treating the incurable cancer-causing virus


Judith A. Smith_UTHealth_007-RE
By Shea Connelly | December 3, 2014

Human papillomavirus, or HPV, is the most common sexually transmitted infection in the United States, affecting between 60 and 80 percent of sexually active adults. Despite its prevalence, there is no cure. A study at The University of Texas Health Science Center (UTHealth) Medical School at Houston, however, could provide hope for people with HPV. It comes in the form of a pill containing an extract derived from an unusual source: mushrooms.

The extract, Active Hexose Correlated Compound (AHCC), comes from shiitake mushrooms and is a readily available nutritional supplement. It has been used to relieve side effects of chemotherapy, which is what originally interested Judith A. Smith, Pharm.D., associate professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at UTHealth Medical School. Smith began studying AHCC a decade ago.

“From a pharmacology perspective, I wanted to rule out any potential drug interactions with chemotherapy,” said Smith. “We then observed some antitumor effects and started digging deeper and learning more about its immune modulating effects.”

Smith and her team spent two years completing in vitro studies showing the effects of AHCC on HPV, largely because they were so taken aback by the results.

“We had a lot of healthy skeptics, and I’ve probably been the biggest of those skeptics. How could this nutritional supplement possibly eradicate one of the most difficult viruses we’ve been challenged with in the cancer arena?” said Smith.

There is no known cure for HPV, and strains of the virus also cause cancer, including cervical cancer, the second most common in women. Without a cure, women infected with HPV are left to wait and see if they develop cancer.

“If they’re tested and we tell them they’re positive, right now there’s nothing we can do. We say, ‘We’ll check you in another year,’” said Smith. “When HPV testing became approved and recommended, I thought, ‘Wow, how frustrating for women.’ It creates a lot of anxiety and feelings of lack of control.”

“We had a lot of healthy skeptics, and I’ve probably been the biggest of those skeptics. How could this nutritional supplement eradicate one of the most difficult viruses we’ve been challenged with in the cancer arena?” — Judith A. Smith, Pharm. D., associate professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at The University of Texas Health Science Center (UTHealth) Medical School at Houston

Vaccines against HPV are available, but the low vaccination rate and the number of people beyond the age of vaccination mean vast numbers of women are infected and left in limbo.

The lack of options inspired Smith to begin researching HPV a decade ago. Despite the success of the in vitro studies, however, she and her team were not convinced of the possible positive effects of AHCC on HPV.

“We did mouse studies and, again, repeated the mouse studies in two models,” said Smith. “We were able to treat with AHCC and eradicate the HPV, then stop treatment and see a durable response.”

That response was key to determining whether AHCC could be truly effective in treating HPV—it wouldn’t just suppress the virus, but eradicate it. Data from a third animal study enabled Smith and her team to tackle the next hurdle: testing the efficacy of AHCC in human patients. Thanks to philanthropic funds, they were able to complete a pilot study treating ten women with the nutritional supplement.

Each of the women in the pilot study was over 30 and had HPV positive persistent infections, meaning they had been infected for 18 months or more. None of the women had cancerous lesions. A main objective of the pilot study was to determine dosage and length of treatment.

Three patients showed complete eradication after stopping AHCC. Two have yet to complete their courses of AHCC, but have tested HPV negative. The remaining patients stopped taking AHCC before testing completely negative. The next step would be a Phase II double-blinded, placebo-controlled trial to confirm the early results of the pilot study.

The regimen they determined involves taking three grams of AHCC on an empty stomach once a day for up to five months. It’s a course of treatment Smith gladly shares.

“It’s definitely in the category of ‘it won’t hurt you,’” said Smith. “Will it definitely help you? I can’t tell you that. I’m not in any position, nor do we have the data, to say yes. We’re not there yet, but we’re trying to get there.”

The success of AHCC so far has been a happy surprise. “We had been looking at this the whole time going, ‘If this works, the potential is huge,’” said Smith. “And now ten years later, the potential could be more than I envisioned.”

Should AHCC studies continue to bring positive results, Smith’s vision is to make the treatment available to as many women as possible, eliminating that limbo between HPV infection and possible cancer diagnosis.

“If further studies confirm our early findings, my ultimate goal would be to be able to find the financial means to support bringing this to underserved patients throughout the world, and here in Texas. That’s where the HPV virus in women with no access to health care is kind of a perfect storm as to why people end up with cancer,” said Smith. “I really want to help those patients.”




Social Posts

Today, Wed. 9-19-2018, I waited 45 minutes for a scheduler to answer the phone, and what could have been done in 15 minutes took almost 50 minute, Just to schedule an appointment. Memorial Hermann was refered by my primary physician. Please Don't Do That. People have things They Need To Do Too! 🤨

5 hours ago
profile_image

Houston Methodist

@MethodistHosp

@bhtrachtenberg Thanks for the shout-out.

6 hours ago
profile_image

Houston Methodist

@MethodistHosp

@uh_con Thanks for sharing the photo.

6 hours ago
profile_image

Houston Methodist

@MethodistHosp

@MrJeremyJackson Thanks for the shout-out.

6 hours ago

I would like to Complain about the customer service of the person at the Memorial Hermann Clinic on Richmond near Kirby Dr. Who Answered The Phone. I waited almost 45 minutes for a lady to answer. Then she acted like I was there to have a conversation with instead of "What do I need as a Customer?" which Is To Schedule an urgent need for x-ray of my knee. They were refered to me by my primary Physician, who's office is a few miles away. I'm disabled due with vision blindness due to a stroke. I depend on public transportation now. In Houston that Is a Huge Challenge for someone who once was able to drive themselves. The person Who Answers The Phone for Appointment Setting MUST Have More Respect for the Person Calling In. It's Just Basic Customer Service and Courtesey. Your Business Was Refered To Me By my Physician. Please Show More Common Courtesy for Your Customer. You Are Going To Lose Business if You Do Not!

6 hours ago
profile_image

Houston Methodist

houstonmethodist

You probably hear about high vs. low cholesterol all the time, but do you really understand how it impacts your health. This video explains the two kinds of cholesterol & why you should know the difference.

8 hours ago
profile_image

Harris Health System

@harrishealth

RT @AlyssaRieber: Everyone needs to learn about @wigoutorg. Nancy is an amazing woman and #survivor who is giving so much to others! We lov…

8 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

Our Dr. Christopher Logothetis shares how we’re overcoming challenges of #prostatecancer with our #CancerMoonshot: https://t.co/8FRKKje8m7 @CancerFrontline #endcancer https://t.co/hPlta0yB7o

9 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

Join @ppisters, @AlyssaRieber and other experts and patients as they discuss ways to improve the #cancer patient experience at our #BidenCancerSummit event: https://t.co/i648448FQs #CancerMoonshot #endcancer https://t.co/EyAsOQ8GGx

9 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

How #cancer treatments can affect your #hearthealth and 4 tips for managing your risk: https://t.co/JFVlWmbYYl #endcancer https://t.co/Mjv6F5LS92

10 hours ago
profile_image

Memorial Hermann

MemorialHermann

After an almost life-ending accident, Artis began a new chapter of his life with a prosthetic leg.“During this time, all I could think about was all of the things I wanted to do despite my circumstances,” he said.Read his story: spr.ly/6185DFYlc.

10 hours ago
profile_image

TAMU Health Sciences

@TAMHSC

#DYK -- There are MORE than 42,000 women currently enrolled in medical school!At @TAMU, we celebrate the @AmerMedicalAssn​’s Women in Medicine Month.#WIMMonth #AggieDocs #TAMHSC #AggieHealth #TAMUHealth #medicine #medicalschool #womendoctors #doctors #HealthCare #YouCanDoIt https://t.co/xltlj6Ef8z

10 hours ago
profile_image

Texas A&M University Health Science Center

TAMUhealthsciences

Did You Know? There are MORE than 42,000 women currently enrolled in medical school!At Texas A&M University, we celebrate the American Medical Association (AMA)​’s Women in Medicine Month.

10 hours ago
profile_image

UTHealth

MyUTHealth

Our diets have a direct impact on our overall health. So how do you know if you are making the best choices for you and your family? Let our nutrition experts help! Join us for our next #UTHealthHouseCalls video web chat TOMORROW, Sept. 20, at 6:30 p.m. on the ABC13 Houston website. Submit your questions there on in the comments below! #ManyFacesOfUTHealth

10 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Veterans Canteen Service provides beds for Veterans exiting homelessness https://t.co/56FwIs3Cxm via #VAntagePoint

10 hours ago